Short-Course Raltegravir Intensification Does Not Increase 2 Long Terminal Repeat Episomal HIV-1 DNA in Patients on Effective Antiretroviral Therapy

समान संसाधन

• Short-course raltegravir intensification does not reduce persistent low-level viremia in patients with HIV-1 suppression during receipt of combination antiretroviral therapy
  द्वारा: McMahon, D., और अन्य
  प्रकाशित: (2010)
• Frequency of Antiretroviral Resistance Mutations among Infants Exposed to Single-Dose Nevirapine and Short Course Maternal Antiretroviral Regimens: ACTG A5207
  द्वारा: Hitti, Jane, और अन्य
  प्रकाशित: (2014)
• No Effect of Raltegravir Intensification on Viral Replication Markers in the Blood of HIV-1-infected Patients Receiving Antiretroviral Therapy
  द्वारा: Gandhi, Rajesh T., और अन्य
  प्रकाशित: (2012)
• Intensification of antiretroviral treatment with raltegravir for pregnant women living with HIV at high risk of vertical transmission
  द्वारा: Puthanakit, Thanyawee, और अन्य
  प्रकाशित: (2018)
• Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy
  द्वारा: Dinoso, J. B., और अन्य
  प्रकाशित: (2009)